CONFERENCE ROUNDUP

IOP reduction sustained for 3 years with MIGS device + phaco

Sustained 36-month IOP and medication reductions were achieved with the second generation Trabecular Micro-Bypass (iStent Inject) plus phacoemulsification, with clinically and statistically greater IOP reduction vs phaco alone, according to a recent poster presentation at 2020 AAO Virtual. The study assessed long-term outcomes of the microinvasive glaucoma surgery (MIGS) device...